Australia markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
146.97-2.73 (-1.82%)
At close: 04:00PM EDT
147.01 +0.04 (+0.03%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
85,648,000
85,159,000
79,990,000
78,740,000
82,584,000
Cost of revenue
26,377,000
26,553,000
24,596,000
23,402,000
28,427,000
Gross profit
59,271,000
58,606,000
55,394,000
55,338,000
54,157,000
Operating expenses
Research development
15,172,000
15,085,000
14,135,000
14,277,000
12,340,000
Selling general and administrative
20,663,000
20,112,000
19,046,000
20,118,000
22,084,000
Total operating expenses
35,835,000
35,197,000
33,181,000
34,395,000
34,424,000
Operating income or loss
23,436,000
23,409,000
22,213,000
20,943,000
19,733,000
Interest expense
715,000
772,000
276,000
183,000
201,000
Total other income/expenses net
-4,087,000
-8,802,000
-3,058,000
-1,635,000
-3,146,000
Income before tax
20,063,000
15,062,000
19,359,000
19,178,000
16,497,000
Income tax expense
2,991,000
1,736,000
2,989,000
1,377,000
1,783,000
Income from continuing operations
17,072,000
13,326,000
16,370,000
17,801,000
14,714,000
Net income
38,476,000
35,153,000
17,941,000
20,878,000
14,714,000
Net income available to common shareholders
38,476,000
35,153,000
17,941,000
20,878,000
14,714,000
Basic EPS
13.42
13.88
6.86
7.93
5.59
Diluted EPS
13.27
13.72
6.73
7.81
5.51
Basic average shares
2,585,225
2,533,500
2,613,597
2,628,965
2,632,512
Diluted average shares
2,615,825
2,560,400
2,663,900
2,674,000
2,670,700